Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus versus sirolimus for renal function after kidney transplantation in older recipients of older-donor kidneys
2005-001854-25Phase 4Active
- Sponsor
- Sociedad Andaluza de Trasplantes de Órganos y Tejidos
- Start
- Oct 2005
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tacrolimus and sirolimus in kidney transplant (2 arms), sponsored by Sociedad Andaluza de Trasplantes de Órganos y Tejidos. Primary endpoint: Serum creatinine at 6 months. Started Oct 2005; status: active.
02
Drugs
tacrolimussirolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2005-001854-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001854-25.